As of 4:02pm ET
| +0.06 / +0.18%|
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It operates through the following geographical segments: UK; Continental Europe; The Americas; Asia, Africa & Australasia. It produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. It distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. The company was founded on April 6, 1999 and is headquartered in London, the United Kingdom.
|Pascal Soriot||Chief Executive Officer & Executive Director|
|Pam P. Cheng||Executive VP-Operations & Information Technology|
|Marc Dunoyer||Chief Financial Officer & Executive Director|
|Sean Bohen||Chief Medical Officer & Executive Vice President|
|Katarina Ageborg||Chief Compliance Officer|